NEIRG Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,720
Closed -$2.68M 64
2023
Q2
$2.68M Sell
5,720
-683
-11% -$286K 0.49% 52
2023
Q1
$2.2M Sell
6,403
-26
-0.4% -$8.77K 0.38% 61
2022
Q4
$2.35M Sell
6,429
-112
-2% -$39.7K 0.44% 66
2022
Q3
$2.12M Sell
6,541
-581
-8% -$184K 0.42% 68
2022
Q2
$2.31M Sell
7,122
-7,339
-51% -$2.2M 0.5% 64
2022
Q1
$4.14M Sell
14,461
-477
-3% -$123K 0.81% 33
2021
Q4
$4.13M Buy
+14,938
New +$3.79M 0.79% 36

Other funds holding LLY

NEIRG Wealth Management's LLY Position: Q3 2023 in Review

NEIRG Wealth Management sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 5,720 shares — an estimated $2.68M sold.

NEIRG Wealth Management first reported a position in LLY in Q4 2021 and held it in 7 quarters. The position peaked at $4.14M in Q1 2022. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • NEIRG Wealth Management reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • NEIRG Wealth Management sold 5,720 Eli Lilly shares in Q3 2023, an estimated $2.68M.
  • NEIRG Wealth Management first reported a position in Eli Lilly in Q4 2021 and held it in 7 quarters.
  • NEIRG Wealth Management's Eli Lilly position peaked at $4.14M in Q1 2022.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on NEIRG Wealth Management's 13F filing for Q3 2023.